Drugs / gp 120 Protein Boost
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01989533 Background | Nov 2013 → Apr 2019 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gp 120 Protein Boost | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01989533 ↗ |
| Modality | Protein / enzyme biologic | “bivalent HIV gp120 glycoprotein” NCT01989533 ↗ |